Clin2
NCT07557355Possibly a fitNot yet recruiting

Testing SRSD384 for Weight Management in Overweight Adults

Overweight , Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new investigational drug called SRSD384 to see if it helps people lose weight or maintain a healthy weight. Researchers want to understand how safe and effective this drug is in adults who are overweight or obese.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
78 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You must be willing to sign a consent form and follow study rules
  • Your BMI (a measure of body weight relative to height) must be between 27.0 and 40.0
  • You cannot have had major surgery in the past 3 months
  • You must not have active cancer in the past 2 years (some skin cancers are okay if treated)
  • You cannot have taken another experimental drug in the past 30 days
  • You must not have received SRSD384 in any previous study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07690826Not yet recruiting· Phase 2
Study of HRS-4729 injection for weight loss in obesity

This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.

Shanghai, Shanghai Municipality
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07280936Recruiting· Phase 1
Study of SHR-2906 in healthy people and those with obesity

This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.

Hangzhou, Zhejiang
NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui
NCT07479862Not yet recruiting· Phase 1
Testing a new injection for overweight or obese adults

This study tests a new injection called SA030 to help people who are overweight or obese. The goal is to see if the study drug is safe and how it works in the body.

Adelaide
NCT07274137Not yet recruiting· Phase 3
Weight-loss drug study for people with obesity or overweight

This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.

Beijing

Hear when a new Overweight , Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.